Response rates and survival after platinum-based chemotherapy in advanced gastroenteropancreatic neuroendocrine carcinoma
Response rates and survival after platinum-based chemotherapy in advanced gastroenteropancreatic neuroendocrine carcinoma
Response rates (A) and survival (B) after platinum-based chemotherapy in advanced gastroenteropancreatic neuroendocrine carcinoma patients according to Ki-67 level in 10% percentiles.
Data from: Sorbye H, Welin S, Langer SW, et al. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study. Ann Oncol 2013; 24:152.
Graphic 98816 Version 1.0
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟